AIM Rule 17 Notification
24 October 2022
Eden Research Plc
("Eden" or the "Company")
AIM Rule 17 Notification
Eden Research Plc (AIM: EDEN) the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries, announces the following additional director disclosure provided pursuant to AIM Rule 17 and Schedule 2(g) of the AIM Rules.
Richard Horsman, Non-executive director of Eden, is Non-executive chairman of Toople Plc ("Toople"). On 21 October 2022, the Directors of Toople appointed an administrator to preserve value for creditors.
For further information contact:
|
Eden Research plc |
|
|
Sean Smith
|
01285 359 555 |
|
|
|
|
Cenkos Securities plc (Nominated advisor and broker) |
|
|
Giles Balleny / Max Gould (corporate finance)
|
020 7397 8900 |
|
|
|
|
Hawthorn Advisors (Financial PR) |
|
|
Victoria Ainsworth
|
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 1 hour ago Johnson Matthey
- 2 hours ago ASOS
- 2 hours ago Coca-Cola Europacific Partners (DI)
- 2 hours ago Liontrust Asset Management
- 2 hours ago Liontrust Asset Management